Dichloroacetate Treatment of Congenital Lactic Acidosis Phase B: Expanded Access

• Status: No longer available
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

Expanded access to DCA as continued treatment for congenital lactic acidosis.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Florida

Criteria

Inclusion Criteria:

• Diagnosis of congenital lactic acidosis

• Participation in Study: #183-1992: Dichloroacetate Treatment of Congenital Lactic Acidosis Exclusion Criteria:

• Intolerance to DCA